MARY GARCIA: Open Payments
NPI 1982221073 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,245 in 81 payments from 20 companies in 2025. Trend: 2023 $8,153 · 2024 $10,509 · 2025 $4,245
Food & beverage: $1,877Speaker / faculty: $1,500Travel & lodging: $843Education: $26
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $2,353 |
| Ferring Pharmaceuticals Inc. | 4 | $548 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $249 |
| Aimmune Therapeutics, Inc. | 7 | $142 |
| Insmed, Inc. | 10 | $142 |
| BioWound Solutions, Inc. | 2 | $139 |
| Merck Sharp & Dohme LLC | 6 | $115 |
| HOSPIRA, INC. | 5 | $76 |
| Octapharma USA, Inc. | 3 | $66 |
| PFIZER INC. | 3 | $65 |
Products named: EMBLAVEO, REBYOTA, CUVITRU, Arikayce, OCTAGAM IMMUNE GLOBULIN (HUMAN), bio-ConneKt, ZERBAXA, ZENPEP.
Industry payments across KS — which companies pay providers there.
